In the Boardroom
Refine Search
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Pharmaceutical
The US subsidiary of Japanese drugmaker Eisai has appointed Dr Luca Dezzani as vice president, US medical affairs, Oncology Business Group. 20 May 2019
Pharmaceutical
UK and USA-based specialty drugmaker EUSA Pharma today announced the strengthening of its senior leadership team with the appointments of Carsten Thiel as president Europe and Darrel Cohen as head of clinical development. 15 May 2019
Pharmaceutical
Jerome Moreau, director for global market access and pricing at UK pharma major GlaxoSmithKline, has taken on a new role at Mundipharma. 14 May 2019
Pharmaceutical
Shanghai and Beijing-based biopharma firm Everest Medicines, which addresses critical unmet medical needs for patients in Greater China and other parts of Asia, has appointed pharmaceutical industry veteran Wende Chen as its chief commercial officer. 11 May 2019
Pharmaceutical
In its pursuit to address the entire scope of Alzheimer's disease (AD), Japanese pharma major Eisai’s US subsidiary is expanding its AD business with the immediate appointments of two renowned experts in the neuroscience field. 4 May 2019
Pharmaceutical
Brent Saunders, the chief executive and chairman of Ireland-headquartered drugmaker Allergan, will suddenly be feeling a lot better ahead of the company’s annual meeting of shareholders on May 1. 17 April 2019
Pharmaceutical
Financing and creating enduring confidence around a deal like Takeda’s $62 million purchase of Shire is not straight forward, but the Japanese drugmaker has hired one of the best operators in his field to help with the task. 16 April 2019
Pharmaceutical
The nominations committee of Swedish firm Calliditas Therapeutics has proposed that Elmar Schnee becomes a board member and chairman of the company. 5 April 2019
Pharmaceutical
Japanese drug major Astellas Pharma (TYO: $4503) has announced two recent senior-level promotions and one new hire within its Medical and Development (M&D) organization. 4 April 2019
Pharmaceutical
Botox (onabotulinumtoxinA) manufacturer Allergan has accepted calls to shake up its management structure, agreeing to create a new position to stand alongside the chief executive at the time of the next leadership change. 25 March 2019
Pharmaceutical
Keld Flintholm Jørgensen has been appointed chief business officer (CBO) heading corporate strategy and business development at Danish CNS specialist Lundbeck. 8 March 2019
Pharmaceutical
Indian drugmaker Glenmark Pharmaceuticals has announced that Alessandro Riva will join its new innovation company as chief executive. The appointment is effective April 2, 2019. 7 March 2019
Pharmaceutical
USA-based Corbus Pharmaceutical has announced the appointment of Craig Millian to the company as its first chief commercial officer ahead of the potential US Food and Drug Administration approval and commercial launch of its lead drug candidate lenabasum in 2021. 5 March 2019
Pharmaceutical
US-based Sunovion Pharmaceuticals, a subsidiary of Japan’s Sumitomo Dainippon Pharma, has appointed Antony Loebel as president and chief executive. 5 March 2019
Pharmaceutical
Mundipharma has appointed Patrice Grand as European director of corporate communications, reporting to Alberto Martinez, president and chief executive in Europe. 18 February 2019
Pharmaceutical
Spanish family-owned drugmaker Esteve has appointed Jordi Muntañola as the new chief commercial officer for Europe, taking on the leadership of all the pharmaceutical activities in Spain and Europe. 15 February 2019
Pharmaceutical
Privately-held French drugmaker Pierre Fabre Group has appointed Maarten Kraan to the position of director of research and development for Pierre Fabre Pharmaceuticals (PFM), reporting to Frédéric Duchesne, chief executive of the Pharmaceuticals Division, and will sit on the branch’s executive committee. 8 February 2019
Pharmaceutical
Appaloosa, the US hedge fund managed by billionaire David Tepper, has called for major and immediate change at Allergan, the Ireland-based drugmaker that is best known for its Botox (onabotulinumtoxinA) product. 6 February 2019
Pharmaceutical
The man leading the UK and Ireland operations in what Takeda calls the company’s ‘new phase’ will be Jon Neal, it has been confirmed. 22 January 2019
Pharmaceutical
Danish CNS specialist Lundbeck today announced that it has appointed Dr Johan Luthman as executive vice president and head of R&D. 22 January 2019
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze